PlexusDx vs ShedRx: GLP-1 Pricing and Terms Compared for 2026

Last reviewed: September 8, 2026 Last updated: September 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

PlexusDx offers lower month-to-month and 6-month pricing for compounded tirzepatide injections, while ShedRx provides a 12-month commitment plan that PlexusDx does not match. On injectable tirzepatide, PlexusDx charges $289 monthly versus ShedRx's $299, saving $120 per year without commitment. At the 6-month tier, PlexusDx's $249 monthly equivalent beats ShedRx's $269, a $240 annual difference. ShedRx's 12-month commitment drops to $239 per month—$2,868 per year—undercutting PlexusDx's lowest comparable injectable plan by $120 annually. ShedRx also lists oral lozenges at $199 monthly, below PlexusDx's oral capsule options ($289–$349), though the specific GLP-1 compound in ShedRx's lozenge product is clinician-dependent and not detailed in verified checkout evidence. ShedRx advertises semaglutide starting at $149, but the plan structure behind that figure was not verified and the company's site contains conflicting promotional rates; confirm current pricing at signup.

At-a-glance comparison: PlexusDx vs ShedRx

Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Normalized pricing: tirzepatide injection over 12 months

Head-to-head tirzepatide injection comparisons depend on commitment length. Month-to-month plans offer maximum flexibility; multi-month commitments reduce the per-month rate but lock you into a contract.

Month-to-month tirzepatide injection

Our calculation: $289 × 12 = $3,468 (PlexusDx); $299 × 12 = $3,588 (ShedRx). ShedRx costs $120 more per year on month-to-month tirzepatide.

6-month commitment tirzepatide injection

Our calculation: $249 × 6 = $1,494 (PlexusDx); $269 × 6 = $1,614 (ShedRx). PlexusDx saves $120 per 6-month cycle, or $240 per year.

12-month commitment tirzepatide injection

ShedRx offers a 12-month commitment plan at $239 per month ($2,868 total), verified September 4, 2026. PlexusDx does not offer a 12-month commitment tier for injectable tirzepatide. Against PlexusDx's lowest long-term option—the 6-month plan at $249/month ($2,988 per year, our calculation)—ShedRx's 12-month commitment saves $120 annually for customers willing to lock in for a full year.

Oral GLP-1 options compared

ShedRx lists oral GLP-1 lozenges at $199 per month (verified September 4, 2026), a significantly lower price point than PlexusDx's oral capsule products. PlexusDx offers semaglutide oral capsules at $289 monthly (month-to-month) and tirzepatide oral capsules at $349 monthly (month-to-month). However, ShedRx's verified pricing page states that the specific oral product is clinician-dependent, and the evidence does not detail whether the $199 lozenge contains semaglutide, tirzepatide, or another GLP-1 compound. If the ShedRx lozenge contains semaglutide, it is $90 per month less expensive than PlexusDx's semaglutide oral; if tirzepatide, $150 per month less expensive than PlexusDx's tirzepatide oral. Confirm the compound and dosing at consultation.

Semaglutide injection pricing: a verification gap

ShedRx's website advertises semaglutide starting at $149 (captured September 4, 2026), but the plan structure, billing frequency, and contract terms behind that figure were not verified at checkout. The company's product pages contain conflicting promotional rates, and the $149 figure may represent an introductory offer, a long-term commitment discount, or a limited-availability tier. PlexusDx's verified semaglutide injection pricing is $189 per month (month-to-month), $169 per month (3-month commitment), and $149 per month (6-month commitment). Until ShedRx's semaglutide plan details are confirmed, a direct comparison is not possible. Verify current semaglutide pricing and terms on ShedRx's site before deciding.

Decision factors beyond price

Contract flexibility

PlexusDx offers month-to-month, 3-month, and 6-month commitment tiers for semaglutide and tirzepatide injections, and month-to-month, 3-month, and 6-month tiers for oral capsules. ShedRx offers month-to-month, 6-month, and 12-month tiers for injectable tirzepatide, and month-to-month oral lozenges. If you want the option to commit for a full year at a lower rate, ShedRx provides that path for tirzepatide injections; PlexusDx does not. If you want shorter incremental steps (3-month plans), PlexusDx offers them.

Dose-dependent pricing

PlexusDx charges the same monthly rate regardless of dose—whether you start at 0.25 mg semaglutide or titrate to 2.4 mg, the price remains $189 monthly (month-to-month plan). ShedRx's dose policies were not captured in the verified evidence. If dose-blind pricing is a priority—especially during titration—confirm ShedRx's policy before enrolling.

Branded medication access

ShedRx offers branded Wegovy and Zepbound in addition to compounded GLP-1s (verified September 4, 2026). PlexusDx does not offer branded products. If you prefer FDA-approved branded medication and are willing to pay the higher cost (and navigate insurance or manufacturer copay programs), ShedRx provides that option.

Review and service transparency

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026). ShedRx has a Trustpilot profile, but no rating or review volume was available at the time of research (September 4, 2026). When service quality and customer feedback are part of your decision criteria, PlexusDx's established review record offers measurable transparency.

Choose PlexusDx if…

• You want the lowest month-to-month tirzepatide injection rate without a long-term contract ($289 vs ShedRx's $299).
• You prefer a 6-month commitment over a full year and want the lowest rate at that tier ($249 vs ShedRx's $269).
• You value dose-blind pricing—paying the same amount whether you are at starter or maintenance dose.
• You want 3-month commitment options for semaglutide or tirzepatide (PlexusDx offers them; ShedRx does not for tirzepatide).
• You rely on transparent customer reviews when evaluating telehealth providers.

Choose ShedRx if…

• You are willing to commit to a full year of tirzepatide injections and want the lowest available rate ($239/month, verified September 4, 2026).
• You want access to branded Wegovy and Zepbound in addition to compounded options.
• You prefer oral lozenges over capsules and the $199 monthly price point fits your budget, and you confirm the GLP-1 compound with your clinician.
• You are comfortable verifying current plan details at signup when promotional rates and contract terms are not fully detailed online.

Methodology and freshness

PlexusDx pricing was verified from product pages and internal documentation between July 17 and July 23, 2026, and cross-checked against rules on September 8, 2026. ShedRx pricing was captured from checkout-visible product pages on September 4, 2026, at 13:49:55 UTC. Where conflicting figures appeared on ShedRx's site (notably the $149 semaglutide teaser), we noted the conflict and recommended confirmation at signup rather than deriving a figure by assumption. All 12-month totals and per-month equivalents for multi-month commitment plans are our calculations, labeled as such. We do not derive promotional prices by discount arithmetic; every published figure was observed directly or calculated transparently from observed rates. Review data for PlexusDx was captured from Trustpilot on September 4, 2026; ShedRx's Trustpilot profile was confirmed to exist but yielded no rating or volume at that date.

Frequently Asked Questions

Does PlexusDx offer a 12-month commitment plan for tirzepatide injections?

No. PlexusDx's longest commitment tier for injectable tirzepatide is 6 months at $249 per month. ShedRx offers a 12-month plan at $239 per month, which is $10 less per month than PlexusDx's 6-month rate.

Is ShedRx's $149 semaglutide price cheaper than PlexusDx?

The $149 figure appeared on ShedRx's site but the plan structure was not verified at checkout. PlexusDx charges $189 month-to-month and $149 on a 6-month commitment for semaglutide injections. Confirm ShedRx's current semaglutide pricing and contract terms before comparing.

Which provider is less expensive for oral GLP-1 medication?

ShedRx's oral lozenges are advertised at $199 per month, well below PlexusDx's semaglutide oral ($289) and tirzepatide oral ($349). However, the specific GLP-1 compound in ShedRx's lozenge is clinician-dependent and was not detailed in verified evidence.

Does either program charge a separate membership fee?

No. Both PlexusDx and ShedRx list $0 membership fees. The monthly rate covers provider visits, prescriptions, compounded medication, and shipping in both programs, according to verified pricing captured in 2026.

Can I switch from ShedRx to PlexusDx or vice versa mid-treatment?

Transferring between telehealth providers is possible but not guaranteed. Each program's clinician will review your records, current dose, and eligibility independently. If you are mid-contract on a multi-month commitment, confirm cancellation and refund policies before initiating a transfer.

Sources

• PlexusDx product pages and internal pricing documentation (verified July 17–23, 2026)
• ShedRx company profile and product catalog (captured September 4, 2026, 13:49:55 UTC)
• ShedRx tirzepatide injection and oral lozenge plan pricing (captured September 4, 2026, 13:49:55 UTC)
• PlexusDx Trustpilot profile (captured September 4, 2026)
• ShedRx Trustpilot profile existence confirmed (captured September 4, 2026; no rating/volume available)

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.